ArticleAntimicrobial agents and chemotherapy2017
Azithromycin Shows Anti-Zika Virus Activity in Human Glial Cells.
Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Repurposing of antibiotics for clinical management of COVID-19: a narrative review.Annals of clinical microbiology and antimicrobials · 2021Review
- Simultaneous electrochemical detection of azithromycin and hydroxychloroquine based on VSMicrochemical journal : devoted to the application of microtechniques in all branches of science · 2021Article
- Revised Korean Society of Infectious Diseases/National Evidence-based Healthcarea Collaborating Agency Guidelines on the Treatment of Patients with COVID-19.Infection & chemotherapy · 2021Review
- Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19.Frontiers in immunology · 2021Review
- Pandemic COVID-19: Current status and challenges of antiviral therapies.Genes & diseases · 2020Article
- Can a metabolism-targeted therapeutic intervention successfully subjugate SARS-COV-2? A scientific rational.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2020Review
- The current understanding and potential therapeutic options to combat COVID-19.Life sciences · 2020Review
- A comprehensive review on drug repositioning against coronavirus disease 2019 (COVID19).Naunyn-Schmiedeberg's archives of pharmacology · 2020Review
- Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity.Journal of lipid research · 2020Review
- Chloroquine as a prophylactic agent against COVID-19?International journal of antimicrobial agents · 2020Article
- The Rationale for Potential Pharmacotherapy of COVID-19.Pharmaceuticals (Basel, Switzerland) · 2020Review
- Erythromycin Estolate Inhibits Zika Virus Infection by Blocking Viral Entry as a Viral Inactivator.Viruses · 2019Article
- Azithromycin Protects against Zika virus Infection by Upregulating virus-induced Type I and III Interferon Responses.Antimicrobial agents and chemotherapy · 2019Article
- ICR suckling mouse model of Zika virus infection for disease modeling and drug validation.PLoS neglected tropical diseases · 2018Article
- Reply to Iannetta et al., "Azithromycin Shows Anti-Zika Virus Activity in Human Glial Cells".Antimicrobial agents and chemotherapy · 2017Article
- Clinical evidences on the antiviral properties of macrolide antibiotics in the COVID-19 era and beyond.Antiviral chemistry & chemotherapyArticle
Corrections and comments
- Commented on by
- Comment on
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.